MSV
BMRN icon

MN Services Vermogensbeheer’s BioMarin Pharmaceuticals BMRN Stock Holding History

MN Services Vermogensbeheer’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-35,500
Closed -$1.92M – 446
2025
Q3 		$1.92M Hold
35,500
– – 0.01% 450
2025
Q2 		$1.95M Hold
35,500
– – 0.01% 458
2025
Q1 		$2.51M Buy
35,500
+3,800
+12% +$256K 0.02% 438
2024
Q4 		$2.08M Hold
31,700
– – 0.01% 461
2024
Q3 		$2.23M Hold
31,700
– – 0.02% 463
2024
Q2 		$2.61M Hold
31,700
– – 0.02% 456
2024
Q1 		$2.77M Sell
31,700
-54,400
-63% -$4.87M 0.02% 463
2023
Q4 		$8.3M Sell
86,100
-3,300
-4% -$292K 0.07% 279
2023
Q3 		$7.91M Hold
89,400
– – 0.08% 275
2023
Q2 		$7.75M Buy
+89,400
New +$8.41M 0.07% 291
2019
Q3 		– Sell
-30,631
Closed -$2.62M – 381
2019
Q2 		$2.62M Hold
30,631
– – 0.03% 475
2019
Q1 		$2.72M Buy
30,631
+500
+2% +$46.3K 0.03% 446
2018
Q4 		$2.24M Buy
30,131
+2,300
+8% +$219K 0.03% 435
2018
Q3 		$2.7M Hold
27,831
– – 0.06% 326
2018
Q2 		$2.62M Sell
27,831
-1,200
-4% -$105K 0.07% 325
2018
Q1 		$2.35M Buy
29,031
+1,900
+7% +$163K 0.06% 345
2017
Q4 		$2.02M Sell
27,131
-1,500
-5% -$130K 0.06% 327
2017
Q3 		$2.67M Hold
28,631
– – 0.07% 303
2017
Q2 		$2.6M Buy
28,631
+24,044
+524% +$2.19M 0.07% 305
2017
Q1 		$376K Buy
4,587
+166
+4% +$14.8K 0.07% 295
2016
Q4 		$347K Buy
4,421
+260
+6% +$22.4K 0.07% 300
2016
Q3 		$385K Buy
4,161
+79
+2% +$7.44K 0.08% 285
2016
Q2 		$286K Buy
4,082
+90
+2% +$7.65K 0.07% 322
2016
Q1 		$289K Buy
+3,992
New +$325K 0.07% 322

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

MN Services Vermogensbeheer's BMRN Position: Q4 2025 in Review

MN Services Vermogensbeheer sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2025, closing a stake of 35,500 shares — an estimated $1.92M sold.

MN Services Vermogensbeheer first reported a position in BMRN in Q1 2016 and held it in 24 quarters. The position peaked at $8.3M in Q4 2023. 539 funds tracked by Wall St. Rank hold BMRN as of Q4 2025.

  • MN Services Vermogensbeheer reported no remaining BioMarin Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • MN Services Vermogensbeheer sold 35,500 BioMarin Pharmaceuticals shares in Q4 2025, an estimated $1.92M.
  • MN Services Vermogensbeheer first reported a position in BioMarin Pharmaceuticals in Q1 2016 and held it in 24 quarters.
  • MN Services Vermogensbeheer's BioMarin Pharmaceuticals position peaked at $8.3M in Q4 2023.
  • 539 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2025.

Based on MN Services Vermogensbeheer's 13F filing for Q4 2025, filed 15 Jan 2026.